nach oben

Erschienen in:

01.03.2005 | Symposium

Roles of Thymosins in Cancers and Other Organ Systems

verfasst von: Changyi Chen, M.D., Ph.D., Min Li, Ph.D., Hui Yang, M.D., Ph.D., Hong Chai, M.D., Ph.D., William Fisher, M.D., Qizhi Yao, M.D., Ph.D.

Erschienen in: World Journal of Surgery | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Abstract

Thymosins are small peptides, originally identified from the thymus, but now known to be more widely distributed in many tissues and cells. Thymosins are divided into three main groups, α-, β-, and γ-thymosins, based on their isoelectric points. α-thymosins (ProTα, Tαl) have nuclear localization and are involved in transcription and/or DNA replications; whereas β-thymosins (Tβ4, Tβ10, Tβl5) have cytoplasmic localization and show high affinity to G-actin for cell mobility. Furthermore, it is well known that both α- and β-thymosins play important roles in modulating immune response, vascular biology, and cancer pathogenesis. More importantly, thymosins may have significant clinical applications. They may serve as molecular markers for the diagnosis and prognosis of certain diseases. In addition, they could be molecular targets of certain diseases or be used as therapeutic agents to treat certain diseases. However, the molecular mechanisms of action of thymosins are largely unknown. This review not only presents recent advances of basic science research of thymosins and their clinical applications but provides thoughtful views for future directions of investigation on thymosins.

Klein, JJ, Goldstein, AL, White, A 1965Enhancement of in vivo incorporation of labeled precursors into DNA and total protein of mouse lymph nodes after administration of thymic extractsProc. Natl. Acad. Sci. U.S.A.53812817PubMed

Low, TLK, Goldstein, AL 1985Thymosin fraction 5 and 5AMethods Enzymol.116219233PubMed

Auger, I, Escola, JM, Gorvel, JP, et al. 1996HLA-DR4 and HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70 kDa heat shock proteinsNat. Med.2306310CrossRefPubMed

Smith, MR 1994Prothymosin alpha: in search of a functionLeuk. Lymphoma18209214

Haritos, AA, Blacher, R, Stein, S, et al. 1985Primary structure of rat thymus prothymosin alphaProc. Natl. Acad. Sci. U.S.A.82343346PubMed

Panneerselvam, C, Haritos, AA, Caldarella, J, et al. 1987Prothymosin alpha in human bloodProc. Natl. Acad. Sci. U.S.A.8444654469PubMed

Franco, FJ, Diaz, C, Barcia, M, et al. 1989Synthesis and apparent secretion of prothymosin alpha by different subpopulations of calf and rat thymocytesImmunology67263268PubMed

Naylor, PH, Friedman-Kien, A, Hersh, E, et al. 1986Thymosin alpha 1 and thymosin beta 4 in serum: comparison of normal, cord, homosexual and AIDS serumInt J Immunopharmacol.8667676CrossRefPubMed

Weller, FE, Shah, U, Cummings, GD, et al. 1992Serum levels of immunoreactive thymosin alpha 1 and thymosin beta 4 in large cohorts of healthy adultsThymus194552PubMed

10.

Hirokawa, K, McClure, JE, Goldstein, AL 1982Age-related changes in localization of thymosin in the human thymusThymus41929PubMed

11.

McClure, JE, Lameris, N, Wara, DW, et al. 1982Immunochemical studies on thymosin: radioimmunoassay of thymosin alpha 1J. Immunol.128368375PubMed

12.

McGilles, JP, Hall, NR, Goldstein, AL 1983Circadian rhythm of thymosin-alpha 1 in normal and thymectomized miceJ. Immunol.131148151PubMed

13.

Gast, K, Damaschun, H, Eckert, K, et al. 1995Prothymosin alpha: a biologically active protein with random coil conformationBiochemistry341321113218CrossRefPubMed

14.

Eschenfeldt, WH, Berger, SL 1986The human prothymosin alpha gene is polymorphic and induced upon growth simulation: evidence using a cloned cDNAProc. Natl. Acad. Sci. U.S.A.8394039407PubMed

15.

Clinton, M, Frangou-Lazaridis, M, Panneerselvam, C, et al. 1989Prothymosin alpha and parathymosin: mRNA and polypeptide levels in rodent tissuesArch. Biochem. Biophys.269256263CrossRefPubMed

16.

Haritos, AA, Tsolas, O, Horecker, BL 1984Distribution of prothymosin alpha in rat tissuesProc. Natl. Acad. Sci. U.S.A.8113911393PubMed

17.

Rubtsov, YP, Zolotukhin, AS, Vorobjev, IA, et al. 1997Mutational analysis of human prothymosin alpha reveals a bipartite nuclear localization signalFEBS Lett.413135141CrossRefPubMed

18.

Conteas, CN, Mutchnick, MG, Palmer, KC, et al. 1990Cellular levels of thymosin immunoreactive peptides are linked to proliferative events: evidence for a nuclear site of actionProc. Natl. Acad. Sci. U.S.A.8732693273PubMed

19.

Manrow, RE, Sburlati, AR, Hanover, JA, et al. 1991Nuclear targeting of prothymosin alphaJ. Biol. Chem.26639163924PubMed

20.

Cordero, OJ, Sarandeses, CS, Nogueira, M 1994Prothymosin alpha receptors on peripheral blood mononuclear cellsFEBS Lett.3412327CrossRefPubMed

21.

Cordero, OJ, Sarandeses, CS, Nogueira, M 1995Prothymosin alpha receptors in lymphocytesJ. Interferon Cytokine Res.15731737PubMed

22.

Eilers, M, Schirm, S, Bishop, JM 1991The MYC protein activates transcription of the α-prothymosin geneEMBO J.10133142PubMed

23.

Enkemann, SA, Pavur, KS, Ryazanov, AG, et al. 1999Does prothymosin alpha affect the phosphorylation of elongation factor 2? JBiol. Chem.2741864418650CrossRef

24.

Tao, L, Wang, RH, Enkemann, SA, et al. 1999Metabolic regulation of protein-bound glutamyl phosphates: Insights into the function of prothymosin αJ. Cell. Physiol.178154163CrossRefPubMed

25.

Gomez-Marquez, J, Rodriguez, P 1998Prothymosin alpha is a chromatin-remodelling protein in mammalian cellsBiochem. J.33313PubMed

26.

Karetsou, Z, Sandaltzopoulos, R, Frangou-Lazaridis, M, et al. 1998Prothymosin alpha modulates the interaction of histone H1 with chromatinNucleic Acids Res.2631113118PubMed

27.

Karetsou, Z, Kretsovali, A, Murphy, C, et al. 2002Prothymosin alpha interacts with the CREB-binding protein and potentiates transcriptionEMBO Rep.3361366PubMed

28.

Rodriguez, P, Vinuela, JE, Alvarez-Fernandez, L, et al. 1998Overexpression of prothymosin alpha accelerates proliferation and retards differentiation in HL-60 cellsBiochem. J.331753761PubMed

29.

Wu, CL, Shiau, AL, Lin, CC 1991Prothymosin alpha promotes cell proliferation in NIH3T3 cellsLife Sci.331753761

30.

Sburlati, AR, Manrow, RE, Berger, SL 1991Prothymosin alpha antisense oligomers inhibit myeloma cell divisionProc. Natl. Acad. Sci. U.S.A.88253257PubMed

31.

Vartapetian, AB, Makarova, TN, Koonin, EV, et al. 1988Small cytoplasmic RNA from mouse cells covalently linked to a proteinFEBS Lett.2323538PubMed

32.

Makarova, T, Grebenshikov, N, Egorov, E, et al. 1989Prothymosin alpha is an evolutionary conserved protein covalently linked to a small RNAFEBS Lett.257247250PubMed

33.

Lukashev, DE, Chichkova, NV, Vartapetian, AB 1999Multiple tRNA attachment sites in prothymosin alphaFEBS Lett.451118124PubMed

34.

Huff, T, Müllie, CSG, Otto, AM, et al. 2001β -Thymosins, small acidic peptides with multiple functionsInt. J. Biochem. Cell. Biol.33205220PubMed

35.

Hannappel, E, Xu, GJ, Morgan, J, et al. 1982Thymosin β4: a ubiquitous peptide in rat and mouse tissuesProc. Natl. Acad. Sci. U.S.A.7921722175PubMed

36.

Young, JD, Lawrence, AJ, MacLean, AG, et al. 1999Thymosin β4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoidsNat. Med.514241427PubMed

37.

Golla, R, Philip, N, Safer, D, et al. 1997Co-ordinate regulation of the cytoskeleton in 3T3 cells overexpressing thymosin-beta 4Cell. Motil. Cytoskeleton38187200PubMed

38.

Bao, L, Loda, M, Janmey, PA, et al. 1996Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancerNat. Med.213221328PubMed

39.

Xu, GJ, Hannappel, E, Morgan, J, et al. 1982Synthesis of thymosin-β4 by peritoneal macrophages and adherent spleen cellsProc. Natl. Acad. Sci. U.SA.7940064009

40.

Hannappel, E, Leibold, W 1985Biosynthesis rates and content of thymosin β4 in cell linesArch. Biochem. Biophys.240236241PubMed

41.

Hannappel, E, Kampen, M 1987Determination of thymosin β4 in human blood cells and serumJ. Chromatogr.397279285PubMed

42.

Clauss, IM, Wathelet, MG, Szpirer, J, et al. 1991Human thymosin β4/6-26 gene is part of a multigene family composed of seven members located on seven different chromosomesGenomics9174180PubMed

43.

Lahn, BT, Page, DC 1997Functional coherence of the human Y chromosomeScience278675680PubMed

44.

Nachmias, VT, Cassimeris, L, Golla, R, et al. 1993Thymosin β4 (Tβ4) in activated plateletsEur. J. Cell. Biol.61314320PubMed

45.

Cassimeris, L, Safer, D, Nachmias, VT, et al. 1992Thymosin β4 sequesters the majority of G-actin in resting human polymorphonuclear leukocytesJ. Cell Biol.1912611270

46.

Yamamoto, M, Shoda, A, Minamino, N, et al. 1992Expression of thymosin β4 gene during Xenopus laevis embryogenesisBiochem. Biophys. Res. Commun.1849399PubMed

47.

Yu, FX, Lin, SC, Morrison-Bogorad, MA, et al. 1993Thymosin β10 and thymosin β4 are both actin monomer sequestering proteinsJ. Biol. Chem.268502509PubMed

48.

Heintz, D, Reichert, A, Mihelic, M, et al. 1993Use of bimanyl actin derivative (TMB-actin) for studying complexation of β-thymosins: inhibition of actin polymerization by thymosin β9FEBS Lett.329912PubMed

49.

Jean, C, Rieger, K, Blanchoin, L, et al. 1994Interaction of G-actin with thymosin β4 and its variants thymosin β9 and thymosin β9 metJ. Muscle Res. Cell Motil.15278286PubMed

50.

Huff, T, Zerzawy, D, Hannappel, E 1995Interactions of β-thymosins, thymosin β4-sulfoxide, and N-terminally truncated thymosin β4 with actin studied by equilibrium centrifugation, chemical cross-linking and viscometryEur. J. Biochem.230650657PubMed

51.

Carlier, MF, Didry, D, Erk, I, et al. 1996Tβ4 is not a simple G-actin sequestering protein and interacts with F-actin at high concentrationJ. Biol. Chem.27192319239PubMed

52.

Sanders, MC, Goldstein, AL, Wang, YL 1992Thymosin β4 (Fx peptide) is a potent regulator of actin polymerization in living cellsProc. Natl. Acad. Sci. U.S.A.8946784682PubMed

53.

Sanger, JM, Golla, R, Safer, D, et al. 1995Increasing intracellular concentrations of thymosin β4 in PtK2 cells: effects on stress fibers, cytokinesis, and cell spreadingCell Motil. Cytoskeleton31307322PubMed

54.

Yu, FX, Lin, SC, Morrison-Bogorad, M, et al. 1994Effects of thymosin β4 and thymosin β10 on actin structures in living cellsCell Motil. Cytoskeleton271325PubMed

55.

Golla, R, Philip, N, Safer, D, et al. 1997Co-ordinate regulation of the Cytoskeleton in 3T3 cells overexpressing thymosin β4Cell Motil. Cytoskeleton38187200PubMed

56.

Sun, HQ, Kwiatkowska, K, Yin, HL 1996Beta-thymosins are not simple actin monomer buffering proteins: insights from overexpression studiesJ. Biol. Chem.27192239230PubMed

57.

Huff, T, Hannappel, E 1997Oxidation and reduction of thymosin β4 and its influence on the interaction with G-actin studied by reverse-phase HPLC and post-column derivatization with fluorescamineAnal. Chim. Acta352249255

58.

, M, Dewitte, D, Goethals, M, et al. 1996The actin binding site of thymosin β4 mapped by mutational analysisEMBO J.15201210PubMed

59.

Carlier, MF, Jean, C, Rieger, KJ, et al. 1993Modulation of the interaction between G-actin and thymosin β4 by the ATP/ADP ratio: possible implication in the regulation of actin dynamicsProc. Natl. Acad. Sci. U.S.A.9050345038PubMed

60.

Thurman, GB, Seals, C, Low, TL, et al. 1984Restorative effects of thymosin polypeptides on purified protein derivative-dependent migration inhibition factor production by the peripheral blood lymphocytes of adult thymectomized guinea pigsJ. Biol. Response Mod.3160173PubMed

61.

Huang, KY, Kind, PD, Jagoda, EM, et al. 1981Thymosin treatment modulates production of interferonJ. Interferon Res.1411420PubMed

62.

Svedersky, LP, Hui, A, May, L, et al. 1982Induction and augmentation of mitogen-induced immune interferon production in human peripheral blood lymphocytes by N alpha-desacetylthymosin alpha 1Eur. J. Immunol.12244247PubMed

63.

Hsia, J, Sarin, N, Oliver, JH, et al. 1989Aspirin and thymosin increase interleukin-2 and interferon-gamma production by human peripheral blood lymphocytesImmunopharmacology17167173PubMed

64.

Zatz, MM, Oliver, J, Samuels, C, et al. 1984Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytesProc. Natl. Acad. Sci. U.S.A.8128822885PubMed

65.

Serrate, SA, Schulof, RS, Leondaridis, L, et al. 1987Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormonesJ. Immunol.13923382343PubMed

66.

Sztein, MB, Serrate, SA 1989Characterization of the immunoregulatory properties of thymosin alpha 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytesInt. J. Immunopharmacol.11789800PubMed

67.

Leichtling, KD, Serrate, SA, Sztein, MB 1990Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytesInt. J. Immunopharmacol.121929PubMed

68.

Ahmed, A, Wong, DM, Thurman, GB, et al. 1979T-lymphocyte maturation: cell surface markers and immune function induced by T-lymphocyte cell-free products and thymosin polypeptidesAnn. N. Y. Acad. Sci.3328194PubMed

69.

Baxevanis, CN, Reclos, GJ, Perez, S, et al. 1987Immunoregulatory effects of fraction 5 thymus peptides. I. Thymosin alpha 1 enhances while thymosin beta 4 suppresses the human autologous and allogeneic mixed lymphocyte reactionImmunopharmacology13133141PubMed

70.

Sztein, MB, Goldstein, AL 1986Thymic hormones—a clinical updateSpringer Semin. Immunopathol.9118PubMed

71.

Schulof, RS, Naylor, PH, Sztein, MB, et al. 1987Thymic physiology and biochemistryAdv. Clin. Chem.26203292PubMed

72.

Frasca, D, Adorini, L, Doria, G 1987Enhanced frequency of mitogen-responsive T cell precursors in old mice injected with thymosin alpha 1Eur. J. Immunol.17727730PubMed

73.

Naylor, PH, Goldstein, AL 1979Thymosin: cyclic nucleotides and T cell differentiationLife Sci.25301310PubMed

74.

Naylor, PH, Thurman, GB, Goldstein, AL 1979Cyclic nucleotide changes in murine lymphocytes following thymosin incubation in vitroImmunopharmacology189101PubMed

75.

Naylor, PH, Thurman, GB, Goldstein, AL 1979Effect of calcium on the cyclic GMP elevation induced by thymosin fraction 5Biochem. Biophys. Res. Commun.90810818PubMed

76.

Baxevanis, CN, Anastasopoulos, E, Reclos, GJ, et al. 1990Prothymosin-α enhances HLA-DR antigen expression on monocytes from patients with multiple sclerosisJ. Neuroimmunol.27141148PubMed

77.

Baxevanis, CN, Thanos, D, Reclos, GJ, et al. 1992Prothymosin alpha enhances human and murine MHC class II surface antigen expression and messenger RNA accumulationJ. Immunol.14819791984PubMed

78.

Kivkina, A, Rybalov, S 2002Chronic hepatitis B: current and future treatment optionsPharmacotherapy22721737PubMed

79.

Sugahara, S, Ichida, T, Yamagiwa, S, et al. 2002Thymosin-alphal increases intrahepatic NKT cells and CTLs in patients with chronic hepatitis BHepatol. Res.24346354PubMed

80.

Baxevanis, CN, Gritzapis, AD, Dedoussis, GVZ, et al. 1994Induction of lymphokine-activated killer activity in mice by prothymosin alphaCancer Immunol. Immunother.38281286PubMed

81.

Baxevanis, CN, Gritzapis, AD, Spanakos, G, et al. 1995Induction of tumor-specific T lymphocyte responses in vivo by prothymosin alphaCancer Immunol. Immunother.40410418PubMed

82.

Papanastasiou, M, Baxevanis, CN, Papamichail, M 1992Promotion of murine antitumor activity by prothymosin alpha treatment I. Introduction of tumoricidal peritoneal cells producing high levels of TNFCancer Immunol. Immunother.35145150PubMed

83.

Gondo, H, Kudo, J, White, JW, et al. 1987Differential expression of the human thymosin-beta 4 gene in lymphocytes, macrophages, and granulocytesJ. Immunol.13938403848PubMed

84.

Hannappel, E, Kampen, M 1987Determination of thymosin beta 4 in human blood cells and serumJ. Chromatogr.397279285PubMed

85.

Schobitz, B, Netzker, R, Hannappel, E, et al. 1991Cell-cycle-regulated expression of thymosin beta 4 in thymocytesEur. J. Biochem.199257262PubMed

86.

Schobitz, B, Netzker, R, Hannappel, E, et al. 1990Rapid induction of thymosin beta 4 in concanavalin A-stimulated thymocytes by translational controlJ. Biol. Chem.2651538715391PubMed

87.

Otero, A, Bustelo, XR, Pichel, JG, et al. 1993Transcript levels of thymosin beta, 4 an actin-sequestering peptide, in cell proliferationBiochim. Biophys. Actal765963

88.

89.

Low, TL, Hu, SK, Goldstein, AL 1981Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populationsProc. Natl. Acad. Sci. U.S.A.7811621166PubMed

90.

Rebar, RW, Miyake, A, Low, TL, et al. 1981Thymosin stimulates secretion of luteinizing hormone-releasing factorScience214669671PubMed

91.

Hall, NR, McGillis, JP, Spangelo, BL, et al. 1985Evidence that thymosins and other biologic response modifiers can function as neuroactive immunotransmittersJ. Immunol.135806s811sPubMed

92.

93.

Kokkinopoulos, D, Perez, S, Papamichail, M 1985Thymosin beta 4 induced phenotypic changes in Molt-4 leukemic cell lineBlut50341348PubMed

94.

Young, JD, Lawrence, AJ, MacLean, AG, et al. 1999Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoidsNat. Med.514241427PubMed

95.

Girardi, M, Sherling, MA, Filler, KB, et al. 2003Anti-inflammatory effects in the skin of thymosin-beta4 splice-variantsImmunology10917PubMed

96.

Malinda, KM, Sidhu, GS, Banaudha, KK, et al. 1998Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healingJ. Immunol.16010011006PubMed

97.

Gokkusu, C, Ademoglu, E, Turkoglu, UM, et al. 1996Thymosin alpha 1 protects liver and aorta from oxidative damage in atherosclerotic rabbitsLife Sci.5910591067PubMed

98.

Grunberg, E, Eckert, K, Maurer, HR, et al. 1997Prothymosin alphal effects on IL-2-induced expression of LFA-1 on lymphocytes and their adhesion to human umbilical vein endothelial cellsJ. Interferon Cytokine Res.17159165PubMed

99.

Grunberg, E, Eckert, K, Maurer, HR 1998Prothymosin alphal antagonizes the inhibitory effects of transforming growth factor-β1 on the adhesion of peripheral blood lymphocytes to human umbilical vein endothelial cellsInt. J. Mol. Med.1741746PubMed

100.

Ademoglu, E, Gokkusu, C, Oz, B 1998Thymosin alpha-1: evidence for an antiatherogenic effectAnn. Nutr. Metab.42283289PubMed

101.

Grant, DS, Kinsella, JL, Kibbey, MC, et al. 1995Matrigel induces thymosin β4 gene in differentiating endothelial cellsJ. Cell Sci.10836853694PubMed

102.

Malinda, KM, Goldstein, AL, Kleinman, HK 1997Thymosin β4 stimulates directional migration of human umbilical vein endothelial cellsFASEB J.11474481PubMed

103.

Frohm, M, Gunne, H, Bergman, AC, et al. 1996Biochemical and antibacterial analysis of human wound and blister fluidEur. J. Biochem.2378692PubMed

104.

Hannappel, E, Kampen, M 1987Determination of thymosin β4 in human blood cells and serumJ. Chromatogr.397279285PubMed

105.

Weber, A, Nachmias, VT, Pennise, CR, et al. 1992Interaction of thymosin β4 with muscle and platelet actin: implications for actin sequestration in resting plateletsBiochemistry3161796185PubMed

106.

Huff, T, Ballweber, E, Humeny, A, et al. 1999Thymosin β4 serves as a glutaminyl substrate of transglutaminase: labeling with fluorescent dansylcadaverine does not abolish interaction with G-actinFEES Lett.4641420

107.

Malinda, KM, Sidhu, GS, Mani, H, et al. 1999Thymosin beta4 accelerates wound healingJ. Invest. Dermatol.113364368PubMed

108.

Philp, D, Badamchian, M, Scheremeta, B, et al. 2003Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged miceWound Repair Regen.111924PubMed

109.

Philp, D, Huff, T, Gho, YS, et al. 2003The actin binding site on thymosin ’beta4 promotes angiogenesisFASEB J...

110.

Grant, DS, Rose, W, Yaen, C, et al. 1999Thymosin beta4 enhances endothelial cell differentiation and angiogenesisAngiogenesis3125135PubMed

111.

Oh, IS, So, SS, Jahng, KY, et al. 2002Hepatocyte growth factor upregulates thymosin beta4 in human umbilical vein endothelial cellsBiochem-Biophys. Res. Commun.296401405PubMed

112.

Vasile, E, Tomita, Y, Brown, LF, et al. 2001Differential expression of thymosin beta–10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosisFASEB J.15458466PubMed

113.

Wu, CG, Boers, W, Reitsma, PR, et al. 1997Overexpression of prothymosin alpha, concomitant with c-myc, during rat hepatic carcinogenesisBiochem. Biophys. Res. Commun.232817821PubMed

114.

Mori, M, Bernard, GF, Staniunas, RJ, et al. 1993Prothymosin a mRNA expression correlates with that of c-myc in human colon cancerOncogene828212826PubMed

115.

Wu, CG, Habib, NA, Mitry, RR, et al. 1997Overexpression of hepatic prothymosin alpha, a novel marker for hepatocellular carcinomaBr. J. Cancer7611991204PubMed

116.

Orre, RS, Cotter, MA, Subramanian, C, et al. 2001Prothymosin a functions as a cellular oncoprotein by inducing transformation of rodent fibroblasts in vitroJ. Biol. Chem.27617941799PubMed

117.

Sasaki, H, Nonaka, M, Fujii, Y, et al. 2001Expression of the prothymosin-a gene as a prognostic factor in lung cancerSurg. Today31936938PubMed

118.

Sasaki, H, Sato, Y, Kondo, S, et al. 2001Expression of the prothymosin alpha mRNA correlated with that of N-myc in neuroblastomaCancer Lett.168191195PubMed

119.

Tsitsilonis, OE, Bekris, E, Voutsas, IF, et al. 1998The prognostic value of alpha-thymosins in breast cancerAnticancer Res.1815011508PubMed

120.

Bianco, NR, Montano, MM 2002Regulation of prothymosin alpha by estrogen receptor alpha: molecular mechanisms and relevance in estrogen-mediated breast cell growthOncogene2152335244PubMed

121.

Mitani, M, Kuwabara, Y, Kawamura, H, et al. 2000Significance of plasma thymosin alphal measurements in gastric cancer patientsWorld J. Surg.24455458PubMed

122.

Garaci, E, Pica, F, Sinibaldi-Vallebona, P, et al. 2003Thymosin alpha (1) in combination with cytokines and chemotherapy for the treatment of cancerInt Immunopharmacol.311451150PubMed

123.

Garaci, E, Pica, F, Rasi, G, et al. 2000Thymosin alpha 1 in the treatment of cancer: from basic research to clinical applicationInt. J. Immunopharmacol.2210671076PubMed

124.

Conlon, JM, Grimelius, L, Wallin, G, et al. 1988Isolation and structural characterization of thymosin-beta 4 from a human medullary thyroid carcinomaJ. Endocrinol.118155159PubMed

125.

Yamamoto, T, Gotoh, M, Kitajima, M, et al. 1993Thymosin beta-4 expression is correlated with metastatic capacity of colorectal carcinomasBiochem. Biophys. Res. Commun.193706710PubMed

126.

Hall, AK 1991Differential expression of thymosin genes in human tumors and in the developing human kidneyInt. J. Cancer48672677PubMed

127.

Clark, EA, Golub, TR, Lander, ES, et al. 2000Genomic analysis of metastasis reveals an essential role for PhoCNature406532535PubMed

128.

Xie, D, Hauch, A, Miller, CW, et al. 2002Discovery of over-expressed genes and genetic alterations in breast cancer cells using a combination of suppression subtractive hybridization, multiplex FISH and comparative genomic hybridizationInt. J. Oncol.21499507PubMed

129.

Kobayashi, T, Okada, F, Fujii, N, et al. 2002Thymosin-β4 regulates motility and metastasis of malignant mouse fibrosarcoma cellsAm. J. Pathol160869882PubMed

130.

Wang, WS, Chen, PM, Hsiao, HL, et al. 2003Overexpression of the thymosin β4 gene is associated with malignant progession of SW480 colon cancer cellsOncogene2232973306PubMed

131.

Weterman, MA, van-Muijen, GN, Ruiter, DJ, et al. 1993Thymosin β10 expression in melanoma cell lines and melanocytic lesions: a new progression marker for human cutaneous melanomaInt. J. Cancer53278284PubMed

132.

Van-Groningen, JJ, Cornelissen, IM, van-Muijen, GN, et al. 1996Simultaneous suppression of progression marker genes in the highly malignant human melanoma cell line BLM after transfection with the adenovirus-5 E1A geneBiochem. Biophys. Res. Commun.225808816PubMed

133.

Verghese-Nikolakaki, S, Apostolikas, N, Livaniou, E, et al. 1996Preliminary findings on the expression of thymosin β10 in human breast cancerBr. J. Cancer7414411444PubMed

134.

Califano, D, Monaco, C, Santelli, G, et al. 1998Thymosin β10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitroCancer58823828

135.

Takano, T, Hasegawa, Y, Miyauchi, A, et al. 2002Quantitative analysis of thymosin beta-10 messenger RNA in thyroid carcinomasJpn. J. Clin. Oncol.32229232PubMed

136.

Sardi, I, Tintori, V 2002Molecular profiling of high-risk neuroblastoma by cDNA arrayInt. J. Mol. Med.9541545PubMed

137.

Santelli, G, Califano, D, Chiappetta, G, et al. 1999Thymosin β10 gene overexpression is a general event in human carcinogenesisAm. J. Pathol.155799804PubMed

138.

Chakravatri, A, Zehr, EM, Zietman, AL, et al. 2000Thymosin β15 predicts for distant failure in patients with clinically localized prostate cancer: results from a pilot studyUrology55635638PubMed

139.

Gold, JS, Bao, L, Ghoussoub, RAD, et al. 1997Localization and quantitation of expression of the cell motility-related protein thymosin β15 in human breast tissueMod. Pathol.1011061112PubMed

140.

Bao, L, Loda, M, Zetter, BR 1998Thymosin β15 expression in tumor cell lines with varying metastatic potentialClin. Exp. Metastasis16227233PubMed

Titel: Roles of Thymosins in Cancers and Other Organ Systems
verfasst von: Changyi Chen, M.D., Ph.D.
Min Li, Ph.D.
Hui Yang, M.D., Ph.D.
Hong Chai, M.D., Ph.D.
William Fisher, M.D.
Qizhi Yao, M.D., Ph.D.
Publikationsdatum: 01.03.2005
Verlag: Springer-Verlag
Erschienen in: World Journal of Surgery / Ausgabe 3/2005
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-004-7817-2

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2005

Second Molecular Surgeon Symposium on Pancreatic Cancer and Other Cancers: An Introduction

Gene Profiling of High Risk Neuroblastoma

Somatostatin, Somatostatin Receptors, and Pancreatic Cancer

Effects of Irradiation Combined with Cis-diamminedichloroplatinum (CDDP) Suppository in Rabbit VX2 Rectal Tumors

Prognosis of Hepatocellular Carcinoma after Hepatectomy in Patients with Renal Dysfunction

Role of Proteases in Pancreatic Carcinoma

Update Chirurgie